EFFICACY AND SAFETY OF PEMETREXED AS SECOND-LINE TREATMENT IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE ANALYSIS

被引：0
|
作者：
Passaro, A. [1 ]
Pochesci, A. [1 ]
Palleschi, M. [1 ]
Pellegrino, A. [2 ]
Fabbri, M. A. [3 ]
Urbano, F. [1 ]
Gentile, V. [1 ]
Manai, C. [1 ]
Pavese, I. [2 ]
Cortesi, E. [1 ]
机构：
[1] Univ Roma La Sapienza, Div Med Oncol, Rome, Italy
[2] San Pietro Fatebenefratelli Hosp, Dept Oncol, Rome, Italy
[3] Osped Belcolle, Dept Med Oncol, Viterbo, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
    Gonzalez, P.
    Ortega-Joaquin, N.
    Provencio Pulla, M.
    Garrido, C.
    Echave, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] TOLERANCE AND EFFICACY OF CHEMOTHERAPY WITH PLATINUM AND PEMETREXED IN ELDERLY PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Leprieur, Etienne Giroux
    Labrune, Sylvie
    Giraud, Violaine
    Gendry, Thierry
    Cobarzan, Daniel
    Chinet, Thierry
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1285 - S1286
  • [3] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Pemetrexed as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Efficacy and correlation with molecular markers
    Blasco, A.
    Sirera, R.
    Terrasa, J.
    Provencio, M.
    Guillen, C.
    Maestu, I.
    de las Penas, R.
    Bover, I.
    Berdiel, M.
    de Aguirre, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] ERLOTINIB (ERL) VERSUS PEMETREXED (MTA) AS SECOND-LINE TREATMENT FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): EFFICACY AND SAFETY DATA
    Zugazagoitia, J.
    Puente, J.
    Hernandez, S.
    Gonzalez-Larriba, J. L.
    Sanz, J.
    Manzano, A.
    Diaz-Rubio, E.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 438 - 439
  • [6] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [7] Clinical Study of Pemetrexed as the First-line Treatment in Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Pu Xiaolin
    Wang Jun
    Li Wei
    Lu Binbin
    Wang Zhaoxia
    Yang Min
    Fan Weifei
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 205 - 209
  • [8] A retrospective study of maintenance pemetrexed in advanced non-squamous non-small cell lung cancer
    Oguh, L.
    Ranatunge, D.
    Lind, M.
    Ukadhyay, S.
    El-Mahdawi, N.
    [J]. LUNG CANCER, 2018, 115 : S30 - S30
  • [9] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC)
    Ding, Lingyu
    Liu, Kejun
    Jiang, Zhelong
    Chen, Qi
    Zhou, Ningning
    Liang, Ying
    Gao, Hongfei
    Hong, Xiangchan
    Wu, Haiying
    [J]. TUMOR BIOLOGY, 2015, 36 (04) : 2491 - 2499
  • [10] Efficacy and safety of second-line immunotherapy in patients with advanced non-small cell lung cancer
    Sanchez Escudero, Laura
    Cobelas Cartagena, Stephanie S.
    Sanchez Esperilla, Maria
    Bayo, Juan L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345